Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
251.60    -2.20 (-0.87%)
Bid:
251.40
Ask:
251.80
Spread: 0.40 (0.159%)
Market Cap: £2.49b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Share Repurchase Programme

5 Mar 2026 07:02

RNS Number : 4039V
Serco Group PLC
05 March 2026
 

LEI: 549300PT2CIHYN5GWJ21

5 March 2026

Serco Group plc

Share Repurchase Programme

 

Serco Group plc (the Company) today announces that, as outlined in the announcement of its 2026 Full Year Results on 5 March 2026, it intends to repurchase shares with a value of up to £75 million (the Programme).

 

This will occur during the period starting on 9 March 2026 and ending no later than 31 July 2026 (the Engagement Period). The aggregate number of shares acquired by the Company shall not exceed the balance of 81,273,394 shares remaining of the 102,385,524 shares authorised by shareholders at the 2025 Annual General Meeting. It is intended that any shares repurchased under the Programme will be transferred into treasury and subsequently cancelled.

 

The Company has entered into an agreement with RBC Europe Limited (RBC) under which RBC will manage the Programme for the Engagement Period. RBC will carry out the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. RBC will make trading decisions in relation to the Programme independently of the Company. During any closed periods, the Company will have no power to invoke any changes to the Programme, and it will be executed at the sole discretion of RBC. This arrangement is in accordance with Chapter 9 of the Financial Conduct Authority's Listing Rules and the Company's general authority to repurchase shares.

 

The Programme will also be conducted in accordance with the parameters of the safe harbour provisions set out in: (i) Article 5(1) of Regulation (EU) 596/2014 (including the delegated and implementing acts adopted under it); and (ii) the provisions of Commission Delegated Regulation (EU) 2016/1052 with regard to regulatory technical standards for the conditions applicable to buyback programmes and stabilisation measures (in each case as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as implemented, retained, amended, extended, re-enacted or otherwise given effect. There is no guarantee that the Programme will be implemented in full.

 

The Company intends to announce any purchase of Ordinary Shares under the Programme in line with the Financial Conduct Authority's Listing Rule 9.6.6, by no later than the end of the 7th daily market session following the date of execution of such purchase.

 

Ends

 

For further information please contact:

 

Jamie Hastings, Head of Investor Relations | +44 (0) 7718 195 074 | jamie.hastings@serco.com

Scot Marchbank, External Communications and Director | +44 (0) 7958 675 706 | scot.marchbank@serco.com

 

 

About Serco

Serco brings together the right people, the right technology, and the right partners to create innovative solutions that make a positive impact and address some of the most urgent and complex challenges facing the modern world.

 

With a primary focus on serving governments globally, Serco's services are powered by more than 50,000 people working across defence, space, migration, justice, healthcare, mobility, and customer services.

 

Serco's core capabilities include service design and advisory, resourcing, complex programme management, systems integration, case management, engineering, and asset & facilities management.

 

Underpinned by Serco's unique operating model, Serco drives innovation and supports customers from service discovery through to delivery.

 

More information can be found at www.serco.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUSAORNBUORUR
Date   Source Headline
31st Mar 20227:00 amRNSTransaction in Own Shares
30th Mar 20223:07 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSTransaction in Own Shares
29th Mar 20227:00 amRNSTransaction in Own Shares
28th Mar 20227:00 amRNSTransaction in Own Shares
25th Mar 20227:00 amRNSTransaction in Own Shares
24th Mar 20227:00 amRNSTransaction in Own Shares
23rd Mar 20227:00 amRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSTransaction in Own Shares
21st Mar 20223:41 pmRNSNotice of AGM
21st Mar 20227:00 amRNSTransaction in Own Shares
18th Mar 20227:00 amRNSTransaction in Own Shares
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSTransaction in Own Shares
15th Mar 20227:00 amRNSTransaction in Own Shares
11th Mar 20227:00 amRNSTransaction in Own Shares
10th Mar 20227:00 amRNSTransaction in Own Shares
9th Mar 20227:00 amRNSTransaction in Own Shares
8th Mar 202212:24 pmRNSAnnual Financial Report
8th Mar 20227:00 amRNSShare Repurchase
1st Mar 202210:05 amRNSTotal Voting Rights
24th Feb 20227:00 amRNS2021 Full Year Results
15th Feb 202211:57 amRNSHolding(s) in Company
10th Feb 20229:52 amRNSHolding(s) in Company
1st Feb 20223:30 pmRNSTotal Voting Rights
26th Jan 202210:10 amRNSHolding(s) in Company
24th Jan 20222:51 pmRNSHolding(s) in Company
20th Jan 20221:42 pmRNSHolding(s) in Company
20th Jan 20221:00 pmRNSDirector Declaration
4th Jan 202210:00 amRNSTotal Voting Rights
24th Dec 202111:50 amRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSCapital Markets Event and initial 2022 guidance
1st Dec 202110:00 amRNSTotal Voting Rights
15th Nov 20217:00 amRNSTrading update
1st Nov 20219:39 amRNSTotal Voting Rights
25th Oct 202110:40 amRNSHolding(s) in Company
11th Oct 20213:07 pmRNSDirector Declaration
1st Oct 202110:06 amRNSTotal Voting Rights
24th Sep 202111:11 amRNSDirectorate Change
22nd Sep 20212:38 pmRNSDirector/PDMR Shareholding
1st Sep 20219:51 amRNSTotal Voting Rights
24th Aug 20214:17 pmRNSDirector/PDMR Shareholding
5th Aug 20217:00 amRNSHalf-year Report
2nd Aug 202110:08 amRNSTotal Voting Rights
2nd Jul 20217:00 amRNSDirector/PDMR Shareholding
1st Jul 202110:16 amRNSTotal Voting Rights
30th Jun 20217:00 amRNSClosed period trading update
29th Jun 202110:00 amRNSDirector/PDMR Shareholding
28th Jun 20217:00 amRNSSerco wins Testing Centres contract rebid
28th Jun 20217:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.